BONNIE HUFF: Open Payments
NPI 1083037477 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,999 in 162 payments from 24 companies in 2025. Trend: 2023 $1,848 · 2024 $2,143 · 2025 $2,999
Food & beverage: $2,987Education: $11
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 47 | $715 |
| Neurocrine BioSciences, Inc. | 15 | $395 |
| Vanda Pharmaceuticals Inc. | 15 | $392 |
| Alkermes, Inc. | 16 | $288 |
| E.R. Squibb & Sons, L.L.C. | 16 | $229 |
| ABBVIE INC. | 10 | $139 |
| Otsuka America Pharmaceutical, Inc. | 10 | $136 |
| Braeburn Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Supernus Pharmaceuticals, Inc. | 3 | $66 |
Products named: CAPLYTA, INGREZZA, FANAPT, ARISTADA, COBENFY, REXULTI, VRAYLAR, BRIXADI.
Industry payments across MO — which companies pay providers there.
